Laurent Dercle Selected Research

Monoclonal Antibodies

1/2020	Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab.
6/2019	Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Dercle Research Topics

Disease

51	Neoplasms (Cancer) 02/2024 - 01/2016
13	Melanoma (Melanoma, Malignant) 11/2023 - 05/2018
9	Hodgkin Disease (Hodgkin's Disease) 09/2022 - 01/2018
5	Neoplasm Metastasis (Metastasis) 07/2023 - 01/2016
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2017
4	Lymphoma (Lymphomas) 01/2021 - 01/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 06/2017
2	Breast Neoplasms (Breast Cancer) 07/2023 - 07/2023
2	Lung Neoplasms (Lung Cancer) 05/2023 - 12/2020
2	Portal Hypertension 05/2022 - 12/2018
2	Glioblastoma (Glioblastoma Multiforme) 07/2021 - 08/2019
2	COVID-19 01/2021 - 01/2020
2	Primitive Neuroectodermal Tumors (PNET) 01/2020 - 01/2019
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2020
1	Paraganglioma (Paragangliomas) 09/2023
1	Pheochromocytoma 09/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Lymphatic Metastasis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Liver Neoplasms (Liver Cancer) 04/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Autoimmune Hypophysitis 01/2019
1	Primary Hyperparathyroidism 01/2019
1	Adenocarcinoma of Lung 12/2018
1	Adenocarcinoma 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Lymphopenia (Lymphocytopenia) 10/2017
1	Thyroid Neoplasms (Thyroid Cancer) 04/2017

Drug/Important Bio-Agent (IBA)

18	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2023 - 04/2017
13	Biomarkers (Surrogate Marker)IBA 09/2023 - 11/2017
10	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2017
5	NivolumabIBA 01/2022 - 01/2020
4	pembrolizumabIBA 03/2022 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 11/2017
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
2	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2021
2	Leucovorin (Folinic Acid)FDA Link 01/2023 - 01/2020
2	afliberceptIBA 01/2023 - 12/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 01/2020
2	AntibodiesIBA 09/2022 - 01/2018
2	Gefitinib (Iressa)FDA Link 01/2020 - 01/2018
2	Monoclonal AntibodiesIBA 01/2020 - 06/2019
2	Cetuximab (Erbitux)FDA Link 01/2020 - 11/2017
2	ErbB Receptors (EGF Receptor)IBA 12/2018 - 01/2018
1	Artificial ReceptorsIBA 11/2023
1	AntigensIBA 11/2023
1	trastuzumab deruxtecanIBA 07/2023
1	pertuzumabIBA 07/2023
1	human ERBB2 proteinIBA 07/2023
1	Trastuzumab (Herceptin)FDA Link 07/2023
1	Immunoconjugates (Immunoconjugate)IBA 07/2023
1	RadiopharmaceuticalsIBA 07/2023
1	EnzymesIBA 01/2023
1	velourIBA 01/2023
1	Deoxyglucose (2 Deoxy D glucose)IBA 09/2022
1	IpilimumabIBA 03/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Gemcitabine FDA Link 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	Panitumumab (Vectibix)FDA Link 12/2020
1	Therapeutic UsesIBA 12/2020
1	Growth Factor ReceptorsIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	FluorineIBA 01/2020
1	DiureticsIBA 09/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	AminesIBA 01/2019
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019
1	Technetium (Technetium 99m)IBA 01/2019
1	Contrast MediaIBA 01/2019
1	vasectrin IIIIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Radioisotopes (Radionuclides)IBA 12/2018
1	Phosphotransferases (Kinase)IBA 05/2018
1	VemurafenibIBA 05/2018
1	Blocking AntibodiesIBA 01/2018
1	IodineIBA 04/2017

Therapy/Procedure

29	Therapeutics 12/2023 - 01/2017
22	Immunotherapy 02/2024 - 10/2017
9	Precision Medicine 11/2023 - 08/2019
6	Drug Therapy (Chemotherapy) 03/2023 - 01/2018
5	Radiotherapy 10/2023 - 01/2018
4	Immunomodulation 10/2023 - 01/2018
2	Brachytherapy 01/2019 - 06/2017
1	Transjugular Intrahepatic Portasystemic Shunt 05/2022
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2022
1	Cystectomy 01/2021
1	Parathyroidectomy 01/2019
1	Chemoradiotherapy 01/2019
1	Stem Cell Transplantation 01/2019